KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Return on Equity: 2011-2025

Historic Return on Equity for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to -0.08%.

  • Dynavax Technologies' Return on Equity fell 12.00% to -0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.08%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of 0.04% for FY2024, which is 6.00% up from last year.
  • Latest data reveals that Dynavax Technologies reported Return on Equity of -0.08% as of Q3 2025, which was up 17.96% from -0.10% recorded in Q2 2025.
  • Dynavax Technologies' Return on Equity's 5-year high stood at 0.70% during Q3 2022, with a 5-year trough of -0.49% in Q1 2021.
  • In the last 3 years, Dynavax Technologies' Return on Equity had a median value of 0.03% in 2024 and averaged 0.05%.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 1,264bps in 2021, then slumped by 60bps in 2023.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Return on Equity stood at 0.66% in 2021, then declined by 12bps to 0.54% in 2022, then plummeted by 55bps to -0.01% in 2023, then rose by 5bps to 0.04% in 2024, then declined by 12bps to -0.08% in 2025.
  • Its Return on Equity was -0.08% in Q3 2025, compared to -0.10% in Q2 2025 and -0.11% in Q1 2025.